ICD-10-PCS Codes

• 1 3E09305 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO NOSE, PERCUTANEOUS APPROACH)

• 2 3E0930M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO NOSE, PERCUTANEOUS APPROACH)

• 3 3E09328 (INTRODUCTION OF OXAZOLIDINONES INTO NOSE, PERCUTANEOUS APPROACH)

• 4 3E09329 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO NOSE, PERCUTANEOUS APPROACH)

• 5 3E0933Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO NOSE, PERCUTANEOUS APPROACH)

• 6 3E0934Z (INTRODUCTION OF SERUM, TOXOID AND VACCINE INTO NOSE, PERCUTANEOUS APPROACH)

• 7 3E093BZ (INTRODUCTION OF ANESTHETIC AGENT INTO NOSE, PERCUTANEOUS APPROACH)

• 8 3E093GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO NOSE, PERCUTANEOUS APPROACH)

• 9 3E093HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO NOSE, PERCUTANEOUS APPROACH)

• 10 3E093KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO NOSE, PERCUTANEOUS APPROACH)

• 11 3E093NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO NOSE, PERCUTANEOUS APPROACH)

• 12 3E093TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO NOSE, PERCUTANEOUS APPROACH)

• 13 3E09705 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 14 3E0970M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 15 3E09728 (INTRODUCTION OF OXAZOLIDINONES INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 16 3E09729 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 17 3E0973Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 18 3E0974Z (INTRODUCTION OF SERUM, TOXOID AND VACCINE INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 19 3E097BZ (INTRODUCTION OF ANESTHETIC AGENT INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 20 3E097GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 21 3E097HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 22 3E097KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 23 3E097NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 24 3E097TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO NOSE, VIA NATURAL OR ARTIFICIAL OPENING)

• 25 3E09X05 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO NOSE, EXTERNAL APPROACH)

• 26 3E09X0M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO NOSE, EXTERNAL APPROACH)

• 27 3E09X28 (INTRODUCTION OF OXAZOLIDINONES INTO NOSE, EXTERNAL APPROACH)

• 28 3E09X29 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO NOSE, EXTERNAL APPROACH)

• 29 3E09X3Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO NOSE, EXTERNAL APPROACH)

• 30 3E09X4Z (INTRODUCTION OF SERUM, TOXOID AND VACCINE INTO NOSE, EXTERNAL APPROACH)

• 31 3E09XBZ (INTRODUCTION OF ANESTHETIC AGENT INTO NOSE, EXTERNAL APPROACH)

• 32 3E09XGC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO NOSE, EXTERNAL APPROACH)

• 33 3E09XHZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO NOSE, EXTERNAL APPROACH)

• 34 3E09XKZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO NOSE, EXTERNAL APPROACH)

• 35 3E09XNZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO NOSE, EXTERNAL APPROACH)

• 36 3E09XTZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO NOSE, EXTERNAL APPROACH)